Global WACh

Gut Health and Child Survival

April 29, 2024

Gut Health team shares experience supporting research consortiums at CUGH 2024

Categories: , ,

Sonia Rao (Project Manager) and Alyson Shumays (Director of Research Operations) at CUGH 2024.

Global WACh team members, Sonia Rao and Alyson Shumays, attended the 2024 Consortium of Universities for Global Health (CUGH) Conference, held from March 7-10, in Los Angeles, CA to share what they’ve learned from supporting international research consortiums under the Gut Health and Child Survival research portfolio.

This year’s theme, “Global Health Without Borders: Acting for Impact,” created an environment for scientists, students and implementers from academia, NGOs, government, and the private sector to learn, share research, collaborate, and develop partnerships to address global health challenges. Global WACh featured two poster abstracts under one of seven subthemes, “Decolonizing – Reforming Global Health Equity, Justice, Global Health Education and Research.” Click the titles below to view the posters. (more…)

April 22, 2024

Enterics for Global Health Consortium publishes a protocol supplement describing the study rationale and methods

Categories: , ,

Sixteen articles authored by the Enterics for Global Health (EFGH) Shigella surveillance study Consortium were recently published in the March 2024 issue of Open Forum Infectious Diseases.

The Enterics for Global Health (EFGH) Shigella surveillance study is a multi-country diarrhea surveillance study that aims to generate key data to optimize the design and implementation of pivotal Shigella vaccine trials. The protocol supplement describes the study rationale and current Shigella vaccine landscape, Consortium governance structure, epidemiologic and laboratory methods, and country site descriptions (Bangladesh, The Gambia, Kenya, Malawi, Mali, Pakistan, and Peru).

(more…)

February 28, 2024

EFGH collaborators convene in Istanbul for pediatric diarrheal disease research

Categories:

Enterics for Global Health collaborators at the InterContinental Hotel in Istanbul, Turkey. (Photo: Emily Allen)

Collaborators of the Enterics for Global Health (EFGH) Shigella surveillance study recently attended a three-day convening in Istanbul, Turkey. The study’s second annual convening gathered nearly 40 collaborators for a series of scientific updates, data analyses planning, and discussions to guide the research consortium into the final stages of the study. (more…)

January 30, 2024

DW3 Spotlight on World NTD Day

Categories: , ,

Malawi census collection. Credit: Wheller, 2016.

On World Neglected Tropical Diseases (NTD) Day, we celebrate the accomplishments of the DeWorm3 study in the fight against NTDs and call on the global health community to renew our commitment to creating a healthier, more equitable world for all.

DeWorm3 is a large clinical trial that aims to determine the feasibility of interrupting the transmission of parasitic worms, known as Soil Transmitted Helminths (STH), through community-wide mass drug administration (cMDA) that provides deworming medication to individuals of all ages in selected communities in Benin, Malawi, and India. STH are associated with nutritional deficiencies, cognitive impairment, and developmental problems amongst people who are heavily infected. The World Health Organization estimates that 1.5 billion individuals are infected with STH, representing 24% of the world’s population. The project began in 2016 with results expected in Spring of 2024. (more…)

January 26, 2024

Announcing the 2023-2024 UW Rising Star Award Recipients

Categories: , ,

The Global WACh and Enterics for Global Health (EFGH) Shigella surveillance study (housed within the center) are pleased to announce the four recipients of the 2023-2024 Rising Star Award cycle.  A goal of the award program was to identify highly talented junior investigators from institutions in low-middle income countries (LMIC) who are committed to a career in research in woman, adolescent, and child health broadly, and in pediatric enteric and diarrheal disease.  To learn more about the award program and previous recipients, visit our informational webpages on the Global WACh and EFGH study sites. Meet our Rising Stars!

(more…)

January 24, 2024

Announcing New Global WACh Faculty Directors

Categories: ,

In late 2023, Global WACh embarked on a search to identify three new Faculty Directors — two internally at Global WACh and one externally among our global partners — to provide key leadership and input on Center-level priorities. They will join the Staff Directors, Kate Rankin and Alyson Shumays. Dr. Grace John-Stewart, the Founding Director, will continue in her role to mentor the new faculty leadership. Together, they will work towards advancing priorities, including social justice initiatives, investing in local and global partnerships, and financial sustainability. We are thrilled to begin the new year with an announcement of the new Faculty Directors: (more…)

November 29, 2023

Dr. Kirk Tickell joins the WHO Technical Advisory Group on Childhood Wasting and Oedema

Categories: ,

Congratulations Dr. Kirk Tickell, MBBS, MPH, PhD, Acting Assistant Professor in the Department of Global Health, who recently joined the Research Sub-Working Group of the WHO Technical Advisory Group on Childhood Wasting and Oedema that advises on important research questions and prioritization in this field. Dr. Tickell joins a multidisciplinary group of experts and key stakeholders with the goal of advising WHO on a broad range of topics and issues related to acute malnutrition to improve the delivery of care and preventative interventions for malnourished children and their families. This convening supports the WHO’s new guideline to tackle acute malnutrition in children under five. (more…)

August 29, 2023

Global WACh PhD trainees defend dissertations in Summer 2023

Categories: , ,

This Summer Quarter, three doctoral students who have spent their PhD journeys with Global WACh, defended their dissertations leveraging research conducted in collaboration with partner institutions around the world. We are thankful for their contributions to advance our science and for the privilege to provide them with mentorship and training support. Congratulations to all! (more…)

August 18, 2023

DeWorm3 study publishes new papers, contributing to research on interrupting parasitic worms through community-wide mass drug administration

Categories: , ,

DeWorm3 study collaborators meeting with community members.

The DeWorm3 research team continues to contribute to their body of research on the feasibility of interrupting soil-transmitted helminth (STH) transmission through community-wide mass drug administration (cMDA) in Benin, Malawi and India. Three new publications to highlight include the “Soil-transmitted helminth surveillance in Benin: A mixed-methods analysis of factors influencing non-participation in longitudinal surveillance activities”, the “Overestimation of school-based deworming coverage resulting from school-based reporting” in PLOS Neglected Tropical Diseases and “Policy stakeholder perspectives on barriers and facilitators to launching a community-wide mass drug administration program for soil-transmitted helminths” in the BMC Global Health Research and Policy.
(more…)

June 14, 2023

New study aims to identify barriers to implementing national sickle cell disease management guidelines in Kenya

Categories: , , , ,

Sickle cell disease (SCD) is a multi-system, life-threatening condition characterized by chronic anemia, frequent episodes of painful vaso-occlusive crises, organ infarction and eventually widespread organ damage. Over 80% of the 240,000 children born with SCD in sub-Sahara Africa each year die before their fifth birthday. Despite the existence of evidence-informed guidelines around the use of disease modifying interventions necessary for the management of SCD, guideline implementation in the region is suboptimal leading to preventable morbidity and mortality. (more…)


Previous page Next page